5903.TWO - Risk

Elevated Business & Solvency Risk

Caution: In addition to price volatility, there are balance sheet risks due to higher debt or weaker liquidity (Health Score: 40/100).

Volatility Risk

Transparent evaluation of price volatility (SRI), Beta, and historical drawdowns.

Volatility Risk Score

5/7 Elevated

5 / 7 SRI Price Fluctuation & Beta

Above-average volatility. Suitable for experienced investors with high risk tolerance (5+ years horizon). Moves noticeably less than the broader market (0.2x).

Beta (Market Relation)

0.16x

Defensive

Volatility (5Y p.a.)

12.6% p.a.

5-Year Horizon

Max Drawdown (5Y)

-31.0%

5-Year Horizon

Sharpe Ratio

-0.71

Return / Risk

Elevated Risk / Growth: Score Basis:

Multi-Horizon Risk & Performance Matrix

Historical volatility, drawdowns, and risk-adjusted return across 1, 3, 5, and 10 years.

Stable Long-Term Volatility

Timeframe	Volatility (p.a.)	Max Drawdown	Sharpe Ratio	Return (p.a.)
1 Year	—	—	—	-2.9%
3 Years	9.9%	-13.0%	-0.39	-1.7%
5 Years	12.6%	-31.0%	-0.71	-6.5%
10 Years	12.9%	-35.5%	-0.31	-1.5%

Automated Risk & Health Notes (Red Flags)

Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).

Critical leverage: Debt-to-Equity is at 363%.

Strong cyclicality: The business model is sensitive to economic downturns.

🔴 Low analyst coverage – higher uncertainty in growth estimates & projections

Strong Long-Term Stability: The stock exhibits consistently low volatility across 5 and 10 years (<16% p.a.).